<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The indication of surgical resection for early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is based on the risk of lymph node extension, which is conditioned by the depth of the lesions </plain></SENT>
<SENT sid="1" pm="."><plain>Even if the high resolution endosonography is more sensitive than conventional endosonography for differentiating mucosal from submucosal lesions, it may be lacking for intermediate lesions (m3 and sm1) </plain></SENT>
<SENT sid="2" pm="."><plain>Macroscopic criteria are useful for identifying high-risk lesions </plain></SENT>
<SENT sid="3" pm="."><plain>In contentious cases, endoscopic resection may be considered as a biopsy to determine the further treatment </plain></SENT>
<SENT sid="4" pm="."><plain>The endoscopic resection is indicated for mucosal lesions in selected patients </plain></SENT>
<SENT sid="5" pm="."><plain>Surgery remains the standard treatment for early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The transhiatal resection is indicated for high-risk T1a mucosal lesions </plain></SENT>
<SENT sid="7" pm="."><plain>The transthoracic resection is indicated for submucosal lesions </plain></SENT>
</text></document>